As part of the Cooperation Practices Agreement, a CPC has a pre-use of controlled and uncontrolled substances.  Pharmacists can assist physicians in treating chronic diseases of street patients in different ways: That our AMA develops standard state legislation to combat the extension of the scope of pharmacist practice, which considers itself inappropriate or constitutes the practice of medicine, including, but not only, the question of the interpretation or application of independent practices without adequate medical supervision. , and to cooperate with interested states and disciplines to advance this legislation (Action Directive).  In the keynote address at the 2013 APH annual meeting, Reid Blackwelder, president of the American Academy of Family Physics (AAFP)  called for a « collaborative vision of public health. »  In 2015, the American College of Clinical Pharmacy (ACCP) published an updated white paper on the management of collaborative drug therapy. CacP regularly publishes updates on this topic, with previous publications in 2003 and 1997. The document describes the recent history of CPAs, legislative advances and discussed payment models for collaborative drug therapy management activities.  For pharmacists, I think you have reached one of the few crossroads that will determine the future of your profession. You will either be your place as a health care provider, or your numbers will decrease, as most donation activities will be replaced by robotics and pharmacy technicians. I am a doctor, and I say that our profession and the patients we serve need you « as a team » as pharmacists. But are you really going to join us?  In 2012, the AAFP prepared a position paper expressing support for CPAs, while highlighting the risk of fragmentation of supply by granting pharmacists fully autonomous prescribing privileges.
 In 2010, the American Medical Association (AMA) published a series of reports entitled « AMA Scope of Practice Data Series. »  One report focused on the pharmacy profession, which criticized the formation of CPAs as an attempt by pharmacists to intervene with the physician. In response to the report, a collaboration of seven national pharmacists` associations prepared a response to the WADA Pharmacists Report.  The response called on WADA to correct its report and publish the revised report with Errata.  In 2011, the WADA Chamber of Deputies adopted a more flexible tone of the APhA in response to contributions from aPhA and other pharmacy professional associations and finally adopted the following resolution, which focuses on the rejection of independent (rather than collaborative or dependent) behavioural agreements: Collaborative Practice Agreements (CPAs) create formal practical relationships between pharmacists and prescription users. CPAs can use collaborative care by defining functions that, in addition to the typical pharmacist`s practice, are delegated to the pharmacist by the co-operative prescriber under negotiated terms defined in the agreement. In addition to the overview below, this resource contains links to the CPA toolkit, a CPA preview site, other resources for CPAs and pharmacy services assistance. CPAs can be used as tools for pharmacists to better integrate into practitioner clinics in responsible procurement offices (OCAs), reduce the time for primary care visits, and minimize delays in the treatment of chronic patients.  The resource helps pharmacists and prescribers navigate the CPA`s network of requirements and adapt a CPA model to best meet their individual clinical, legal and administrative circumstances.